Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 10;8(1):43.
doi: 10.1038/s41421-022-00411-4.

Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2

Yifan Lin #  1 , Jing Sun #  2 , Xuezhi Cao #  3 , Xiuye Wang  3 , Xi Chen  4 , Hairong Xu  1 , Jincun Zhao  5   6 , Yang-Xin Fu  7 , Hua Peng  8   9
Affiliations

Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2

Yifan Lin et al. Cell Discov. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

X.Chen is an employee of LivzonBio Inc., China. Other authors declare no conflict of interests.

Figures

Fig. 1
Fig. 1. Intranasal administration of IPRF-induced robust IgG and IgA responses against SARS-CoV-2.
C57BL/6 mice (n = 10) were i.n. immunized with 10 μg IPRF, equal molar of RBD, or PBS. a Antibody levels in sera of immunized mice were evaluated weekly after prime and boost vaccination. b The viral neutralization antibody titer (NAbs) of vaccinated sera and nasal mucosal collected on day 42 was evaluated using a pseudovirus neutralization assay. c The hACE2-transgene mice (n = 10) were i.n. immunized with 10 μg IPRF, equal molar of RBD or PBS twice on days 0 and 14. Mice were challenged with authentic SARS-CoV-2 6 weeks post the boost dose. Five mice in each group were euthanized 2 days post challenge. The other five mice in each group were euthanized 1 week post challenge. Viral RNA copies in the lung of each mouse were determined by qRT-PCR and plotted as log10 copies per mL. d–f C57BL/6 mice (n = 10) were i.n. or i.m. immunized with 10 μg IPRF. d RBD-specific IgA response in sera and nasal mucosal homogenate supernatant on day 42 was measured by ELISA. e Vaccinated mouse nasal mucosal collected on day 42 was evaluated using a WT pseudovirus neutralization assay. f The neutralization activity was evaluated using an Omicron pseudovirus neutralization assay. g The hACE2-transgene mice (n = 8) were i.n. or i.m. immunized with 10 μg IPRF or PBS twice on days 0 and 14. Mice were challenged with authentic SARS-CoV-2 12 weeks post the boost dose. Mice in each group were euthanized 3 days post challenge. Viral RNA copies in the nasal of each mouse were determined by qRT-PCR and plotted as log10 copies per mL. The data shown are presented as mean ± SEM. P values were determined by one-way ANOVA with multiple comparison tests. ns, not significant; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
See this image and copyright information in PMC

References

    1. World Health Organization. COVID-19 Weekly Epidemiological Update 68th edn (2021).
    1. Cloete, J. et al. Rapid rise in paediatric COVID-19 hospitalisations during the early stages of the Omicron wave, Tshwane District, South Africa. medRxivhttps://www.medrxiv.org/content/10.1101/2021.1112.1121.21268108v21268101 (2021). - DOI
    1. Zhao, X. et al. Reduced sera neutralization to Omicron SARS-CoV-2 by both inactivated and protein subunit vaccines and the convalescents. bioRxivhttps://www.biorxiv.org/content/10.1101/2021.1112.1116.472391v472391 (2021). - DOI
    1. Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature602, 664–670 (2022). - PMC - PubMed
    1. Bleier BS, Ramanathan M, Jr, Lane AP. COVID-19 vaccines may not prevent nasal SARS-CoV-2 infection and asymptomatic transmission. Otolaryngol. Head. Neck Surg. 2021;164:305–307. doi: 10.1177/0194599820982633. - DOI - PubMed